No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
INM InMed Pharmaceuticals
- 0.3030
- +0.0300+10.99%
Close Apr 24 16:00 ET
- 0.2670
- -0.0360-11.88%
Post 19:59 ET
1.84MMarket Cap-721P/E (TTM)
0.3370High0.2700Low3.61MVolume0.2890Open0.2730Pre Close1.08MTurnover74.48%Turnover RatioLossP/E (Static)6.06MShares2.080052wk High0.14P/B1.47MFloat Cap0.262052wk Low--Dividend TTM4.85MShs Float160.5000Historical High--Div YieldTTM24.54%Amplitude0.2620Historical Low0.2980Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | InMed Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/644,484 Titled "Metabolic Engineering Of E. Coli For The Biosynthesis Of Cannabinoid Products"
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results.Tesla posted weaker-than-expected earnings and sales results for its first quarter on Tue
InMed Pharmaceuticals Welcomes Alzheimer's Expert
InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board
Vancouver, British Columbia–(Newsfile Corp. – April 18, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the research, development, manufacturing, and commercia
InMed Pharmaceuticals Preclinical Success With INM-089
Express News | InMed Pharmaceuticals INM-089 Presented Neuroprotection Of Photoreceptors As Well As Improved Photoreceptors Function; Improved Integrity Of Retinal Pigment Epithelium; And Reduction In Extracellular Autofluorescent Deposits, A Hallmark Of Dry AMD
Comments
Update
$InMed Pharmaceuticals(INM.US$ InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
News
$InMed Pharmaceuticals(INM.US$ InMed Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/098,324 Titled "Use Of Topical Formulations Of Cannabinoids In The Treatment Of Epidermolysis Bullosa And Related Connective Tissue Disorders"
$InMed Pharmaceuticals(INM.US$ earnings beat, should throw a 13G filing in also. All the cool companies are doing it
1
Top investments
Best stocks for long and short:
$Jeffs' Brands(JFBR.US$ In an uptrend. Short sellers will cover when they run out of time or spot an oppurtunity to get cheap shares.
$LQR House(LQR.US$ Skyrocketing borrow rate due to low float. Their prospectus wasnt closed so the underwriters could have used their rights to buy about 200,000 shares which would explain the price movement with a volume of 2 million. The stock price cant fall below 1.00 or they will be delisted. Im in at 1.25 a...
$Jeffs' Brands(JFBR.US$ In an uptrend. Short sellers will cover when they run out of time or spot an oppurtunity to get cheap shares.
$LQR House(LQR.US$ Skyrocketing borrow rate due to low float. Their prospectus wasnt closed so the underwriters could have used their rights to buy about 200,000 shares which would explain the price movement with a volume of 2 million. The stock price cant fall below 1.00 or they will be delisted. Im in at 1.25 a...
10
5
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg